Cargando…
Temporal and Wash-Out Studies Identify Medicines for Malaria Venture Pathogen Box Compounds with Fast-Acting Activity against Both Trypanosoma cruzi and Trypanosoma brucei
Chagas disease caused by the protozoan Trypanosoma cruzi is endemic to 21 countries in the Americas, effects approximately 6 million people and on average results in 12,000 deaths annually. Human African Trypanosomiasis (HAT) is caused by the Trypanosoma brucei sub-species, endemic to 36 countries w...
Autores principales: | Sykes, Melissa L., Kennedy, Emily K., Read, Kevin D., Kaiser, Marcel, Avery, Vicky M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317670/ https://www.ncbi.nlm.nih.gov/pubmed/35889006 http://dx.doi.org/10.3390/microorganisms10071287 |
Ejemplares similares
-
Repetitive DNA is associated with centromeric domains in Trypanosoma brucei but not Trypanosoma cruzi
por: Obado, Samson O, et al.
Publicado: (2007) -
Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major
por: Passos-Silva, Danielle Gomes, et al.
Publicado: (2010) -
Impact of Laboratory-Adapted Intracellular Trypanosoma cruzi Strains on the Activity Profiles of Compounds with Anti-T. cruzi Activity
por: Sykes, Melissa L., et al.
Publicado: (2023) -
Trypanosoma brucei and Trypanosoma cruzi DNA Mismatch Repair Proteins Act Differently in the Response to DNA Damage Caused by Oxidative Stress
por: Grazielle-Silva, Viviane, et al.
Publicado: (2020) -
Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi
por: Parsons, Marilyn, et al.
Publicado: (2005)